American Well Corporation
NYQ: AMWLLive Quote
📈 ZcoreAI Score
Our AI model analyzes American Well Corporation's price action across multiple timeframes using regression channels and statistical scoring.
Get AMWL Z-Score →About American Well Corporation
Healthcare
Health Information Services
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings; Amwell Converge, a platform and wraparound services of digital care into the in-person, automated, and virtual care settings; and Behavioral Health, a platform that offer students and faculty the right level of care. It also provides specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members; Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
📊 Fundamental Analysis
American Well Corporation demonstrates a profit margin of -38.4%, which is below the sector average, suggesting competitive pressure.
The company recently reported -22.1% revenue growth, which is negative, indicating a recent decline in revenue.
Return on Equity (ROE) is -33.7%, which indicates that capital utilization is currently under pressure.
At a current price of $5.19, AMWL currently sits at the 27th percentile of its 52-week range (Range: $3.71 - $9.15).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
🔴
Revenue Growth
Weak
🔴
Return on Equity
Weak
🔴
Beta (Risk)
High Volatility
Key Financials
Market Cap
$85.90M
Trailing P/E
--
Forward P/E
-2.62
Beta (5Y)
1.39
52W High
$9.15
52W Low
$3.71
Avg Volume
85K
Day High
Day Low